Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02733250
Title Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer (URCOH-PMS-001)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Centre hospitalier de l'Université de Montréal (CHUM)

lung non-small cell carcinoma


Nab-paclitaxel + Pembrolizumab

Age Groups: adult
Covered Countries CAN

Additional content available in CKB BOOST